Life Sciences and healthcare organizations who are adopting powerful NGS genomics data analysis face important challenges. They need to process and manage voluminous and complex omics data, while also ensuring that they have a secure, scalable, and flexible platform that supports product growth. Building this infrastructure requires significant financial investment and a lengthy development process.

In this webinar, featured presenter, Clint Valentine, Sr. Director of Data Sciences from TwinStrand Biosciences, will share how TwinStrand developed technology for detecting ultra-low frequency genetic variants, not possible by conventional methods, using a modern cloud-based data analysis platform. Learn how TwinStrand overcame the “needle in a haystack” dilemma for those that routinely analyze billions of raw reads across various application areas including genetic toxicology, oncology, and cell therapy. Topics covered include:

• Challenges and opportunities of using Low Frequency and Rare Variants in Personalized Medicine
• Ways to significantly speed up turnaround time for faster scientific discovery and optimized speed-to-market
• Considerations in using modern technology to meet robust data security and privacy requirements, as well as resource management concerns